Berit Rabausch
Overview
Explore the profile of Berit Rabausch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Homann S, Grandoch M, Kiene L, Podsvyadek Y, Feldmann K, Rabausch B, et al.
Matrix Biol
. 2017 Oct;
66:67-80.
PMID: 28987865
Objective: Hyaluronan (HA) is a prominent component of the provisional extracellular matrix (ECM) present in the neointima of atherosclerotic plaques. Here the role of HA synthase 3 (HAS3) in atheroprogression...
2.
Kiene L, Homann S, Suvorava T, Rabausch B, Muller J, Kojda G, et al.
Arterioscler Thromb Vasc Biol
. 2015 Nov;
36(2):e9-16.
PMID: 26586662
Objective: Hyaluronan (HA) is a polymeric glucosaminoglycan that forms a provisional extracellular matrix in diseased vessels. HA is synthesized by 3 different HA synthases (HAS1, HAS2, and HAS3). Aim of...
3.
Grandoch M, Feldmann K, Gothert J, Dick L, Homann S, Klatt C, et al.
Circ Res
. 2015 Mar;
116(8):e57-68.
PMID: 25740843
Rationale: Lymphotoxin β receptor (LTbR) regulates immune cell trafficking and communication in inflammatory diseases. However, the role of LTbR in atherosclerosis is still unclear. Objective: The aim of this study...
4.
Dai G, Freudenberger T, Zipper P, Melchior A, Grether-Beck S, Rabausch B, et al.
Am J Pathol
. 2007 Nov;
171(5):1451-61.
PMID: 17982124
Remodeling of the dermal extracellular matrix occurs during photoaging. Here, the effect of repetitive UVB irradiation on dermal hyaluronic acid (HA) was examined. C57/BL6 mice were chronically (182 days) irradiated...
5.
Dienst A, Grunow A, Unruh M, Rabausch B, Nor J, Fries J, et al.
J Natl Cancer Inst
. 2005 May;
97(10):733-47.
PMID: 15900043
Background: The tumor vasculature is increasingly recognized as a target for cancer therapy. We developed and evaluated recombinant fusion proteins targeting the coagulation-inducing protein soluble tissue factor (sTF) to the...